US Patent Issued to SEKISUI MEDICAL, NATIONAL INSTITUTES OF BIOMEDICAL INNOVATION, HEALTH AND NUTRITION on June 17 for "Leucine-rich ALPHA2 glycoprotein composition" (Japanese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,092, issued on June 17, was assigned to SEKISUI MEDICAL Co. LTD. (Tokyo) and NATIONAL INSTITUTES OF BIOMEDICAL INNOVATION, HEALTH AND NUTRITION (Ibaraki, Japan).

"Leucine-rich ALPHA2 glycoprotein composition" was invented by Shigeo Takayama (Tokyo), Tetsuji Naka (Ibaraki, Japan) and Satoshi Serada (Ibaraki, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object is to provide a leucine-rich Alpha2 glycoprotein composition comprising leucine-rich Alpha2 glycoprotein and having excellent preservation stability. The object can be achieved by a leucine-rich Alpha2 glycoprotein composition comprising leucine-rich Alpha2 glycoprotein and having a p...